HALO logo
halo search icon
EDAP TMS SA Sponsored ADR

US$4.65

Price Change Indicator
-0.13 (-2.72%)
EDAP TMS SA Sponsored ADR
FOCL · NAS

EDAP TMS SA Sponsored ADR

Start Trading FOCL for Free

US$4.65

Price Arrow-0.13 (-2.72%)
02/06/2026 04:00:01 PM
All-ConsensusBig CandleHammer Bullish (Realtime)Near Resistance
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EDAP TMS SA Sponsored ADR Overview

FOCL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About FOCL

icon
icon

Telephone

icon

Address

Description

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

FOCL Price Chart

Key Stats

Market Cap

US$179.16M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.21 - 5.05

Trade Value (12mth)

US$45,536.00

1 week

13.81%

1 month

37.75%

YTD

40.59%

1 year

166.3%

All time high

21.64

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

0.00%

Operating Cashflow

-$19m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

37m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

FOCL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklockN/AN/A-0.8locklocklock
EPS (Fully Diluted)
 $locklocklocklockN/AN/AN/Alocklocklock
Growth
 %locklocklocklockN/AN/AN/Alocklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of EDAP TMS SA Sponsored ADR (FOCL:NAS)?
Halo FAQ
The current share price of EDAP TMS SA Sponsored ADR (FOCL:NAS) is USD$4.65.
What is the 52-week high share price for EDAP TMS SA Sponsored ADR (FOCL:NAS)?
Halo FAQ
The 52-week high share price for EDAP TMS SA Sponsored ADR (FOCL:NAS) is USD$5.05.
What is the 52-week low share price for EDAP TMS SA Sponsored ADR (FOCL:NAS)?
Halo FAQ
The 52-week low share price for EDAP TMS SA Sponsored ADR (FOCL:NAS) is USD$1.21.
What is the dividend yield for EDAP TMS SA Sponsored ADR (FOCL:NAS)?
Halo FAQ
EDAP TMS SA Sponsored ADR (FOCL:NAS) does not pay a dividend.
What was EDAP TMS SA Sponsored ADR (FOCL:NAS) last dividend payment?
Halo FAQ
EDAP TMS SA Sponsored ADR (FOCL:NAS) does not pay a dividend.
What is the franking level for EDAP TMS SA Sponsored ADR (FOCL:NAS)?
Halo FAQ
EDAP TMS SA Sponsored ADR (FOCL:NAS) has a franking level of 0.00%.
In which sector is EDAP TMS SA Sponsored ADR (FOCL:NAS) classified?
Halo FAQ
EDAP TMS SA Sponsored ADR (FOCL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial